Structure via PubChem · Public domain (PubChem)
اپروبماید
Sign in to saveAlso known as Бефол
Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol). It is a non-competitive reversible inhibitor of monoamine oxidase A that exhibits selective action on serotonin deamination. Eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.
In the Vinony graph
Vinony's link graph records 451 inbound references to اپروبماید, and connects out to L-tyrosine, monoamine oxidase inhibitor and tetracyclic antidepressant.
It is catalogued under topics including 4-Chlorophenyl compounds, 4-Morpholinyl compounds and Antidepressants.
Vinony links it to 5 Wikipedia language editions.
Chemical data
- Formula
- C14H19ClN2O2
- Molecular weight
- 282.76 g/mol
- IUPAC name
- 4-chloro-N-(3-morpholin-4-ylpropyl)benzamide
- SMILES
- C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
- InChIKey
- YYFGRAGNYHYWEZ-UHFFFAOYSA-N
- XLogP
- 1.8
- Polar surface area
- 41.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Phase 2
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 282.114
Show 3 more facts
- Commons category
- Eprobemide
- chemical formula
- C₁₄H₁₉ClN₂O₂
- canonical SMILES
- C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
Sources (2)
via Wikidata · CC0